CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
By V. Leuci, G. M. Casucci, G. Grignani, R. Rotolo, U. Rossotti, E. Vigna, L. Gammaitoni, G. Mesiano, E. Fiorino, C. Donini, A. Pisacane, L. D. Ambrosio, Y. Pignochino, M. Aglietta, A. Bondanza and D. Sangiolo
Topics:
adoptive immunotherapy; CAR; CD44v6; CIK; soft tissue sarcoma; Immunology and Allergy; Immunology; Oncology
Publisher: 'Informa UK Limited'
Year: 2018
DOI identifier: 10.1080/2162402X.2017.1423167
OAI identifier:
oai:iris.unito.it:2318/1669344